PTC Therapeutics Reports Second Quarter 2019 Financial Results and Provides a Corporate Update

Go back to PTC Therapeutics Reports Second Quarter 2019 Financial Results and Provides a Corporate Update
PTC THERAPEUTICS (NASDAQ: PTCT) Delayed: 85.44 +2.13 (2.56%)
Previous Close $83.31    52 Week High $35.40 
Open $84.14    52 Week Low $4.03 
Day High $87.07    P/E 9.09 
Day Low $82.70    EPS $9.40 
Volume 3,805,583